TMCnet News
otcstockexchange.com: POTP, WWAT, SIBE, VSPC - OTCStockExchange.com Stock Alert(M2 PressWIRE Via Thomson Dialog NewsEdge) RDATE:17102007 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Point Therapeutics, Inc. (Nasdaq: POTP), WorldWater & Solar Technologies Corp. (OTCBB: WWAT), Sibling Entertainment Group Holdings, Inc. (OTCBB: SIBE), VIASPACE Inc. (OTCBB: VSPC). Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com ! Point Therapeutics, Inc. (Nasdaq: POTP - http://finance.yahoo.com/q?s=potp ) (Wed, October 17, 2007, 7:00am EDT) DARA BioSciences, Inc. and Bayer Pharmaceuticals Corporation (BPC), a U.S. subsidiary of Bayer HealthCare AG signed a license agreement granting DARA BioSciences exclusive worldwide rights to a series of patents and compounds for the treatment of metabolic diseases, in particular type 2 diabetes and dyslipidemia. Lead compounds are in later preclinical development. Under the terms of the agreement DARA BioSciences will develop and commercialize products while Bayer will receive an upfront payment, milestone payments and royalties during the development and commercialization. In addition, Bayer has certain rights to commercialize products emanating from this development program. Richard A. Franco, Sr., President and Chief Executive Officer, stated, "DARA BioSciences' licensing-in of the Bayer technology demonstrates our commitment to exploring new alternatives in the treatment of metabolic diseases including diabetes. This transaction also demonstrates our continuing success in executing our strategy to identify new opportunities in order to expand and diversify our product portfolio. We look forward to the opportunity to work with Bayer." The WHO estimates that globally over 170 million people have diabetes. Type 2 diabetes accounts for 90% to 95% of all cases of diabetes. Worldwide the costs associated with treating diabetes and its complications are estimated to exceed $200 billion a year. By 2030 the prevalence of diabetes is predicted to double, driven by adverse lifestyle changes which have seen an explosion in the incidence of obesity, a risk factor for type 2 diabetes. Worldwide, diabetes is a huge and growing problem for which new treatments are needed. About Bayer HealthCare The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com. About DARA BioSciences, Inc. DARA BioSciences(TM), Inc. ("DARA") is a Raleigh, North Carolina-based development-stage pharmaceutical company that acquires promising therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses its therapeutic development efforts on small molecules from late preclinical development through phase 2 clinical trials. DARA is developing a portfolio of therapeutic candidates for neuropathic pain, metabolic diseases including type 2 diabetes, and dermatological disorders. On October 10, 2007, DARA announced an agreement to merge with Point Therapeutics, Inc. WorldWater & Solar Technologies Corp. (OTCBB: WWAT - http://finance.yahoo.com/q?s=WWAT.OB ) (Mon, October 15, 2007, 3:01am EDT) WorldWater & Solar Technologies Corp., developer and marketer of proprietary high-power solar systems, and ENTECH, Inc. of Keller, Texas, a high tech supplier of solar technology to NASA for space operations, announced today that they have signed an extension of their Letter of Intent (LOI) to merge from October 15, 2007 to November 30, 2007 pending final signatures of the Merger Agreement. The companies are jointly preparing the construction line for the ENTECH 20 X concentrator solar systems for volume production and installation in the second quarter of 2008. Sibling Entertainment Group Holdings, Inc. (OTCBB: SIBE - http://finance.yahoo.com/q?s=SIBE.OB ) (Wed, October 17, 2007, 7:30am EDT) Sibling Entertainment Group Holdings, Inc. ["Sibling Holdings"] announced Sibling Theatricals, Inc. ["Sibling Theatricals"], a wholly-owned subsidiary of Sibling Entertainment Group, Inc., has signed an agreement with Garlin Holdings Limited to form Richfield Entertainment, LLC, (a Delaware limited liability company) for the purpose of developing and funding new projects. Sibling Entertainment Group, Inc. is the company with which Sibling Holdings has previously signed an Agreement of Acquisition and Plan of Reorganization, the closing of which is currently pending. (see "Note to Editor" below for an explanation of Sibling Holdings relationship to Sibling Entertainment Group, Inc. and Sibling Theatricals). Richfield Entertainment LLC ("Richfield Entertainment") is a joint venture between Sibling Theatricals and Garlin Holdings Limited (a Jersey private limited company) ("Garlin Holdings") which will allow Sibling Theatricals to expand its operations in the United States and to pursue entertainment ventures in Russia, Asia, and Europe. Sibling Theatricals will retain a twenty-five (25%) interest in Richfield Entertainment. Richfield Entertainment has been granted a limited option to finance and fund future projects developed by Sibling Theatricals with the primary source of funding to be provided by Garlin or sources introduced by Garlin Holdings. "We are excited to create a joint venture with Garlin Holdings Limited that will help fund some of our new projects being developed for Broadway. The creation of Richfield Entertainment supports our long range strategy to build a world-class entertainment company," said Mitchell Maxwell, Chairman and CEO of Sibling Entertainment Group, Inc. (and Sibling Holdings). In addition, "On September 30, 2007, Richfield completed the first round of financing of $700,000 for the development of new works by Sibling Theatricals with Richfield Entertainment," he said. Richfield Entertainment LLC will announce its plans for 2 upcoming Broadway productions shortly. VIASPACE Inc. (OTCBB: VSPC - http://finance.yahoo.com/q?s=VSPC.OB ) (Wed, October 17, 2007, 2:30am EDT) VIASPACE Inc., a company dedicated to commercializing proven technologies from NASA and the US Department of Defense, announced today that its VIASPACE Energy Division, including subsidiary Direct Methanol Fuel Cell Corporation (DMFCC), are exhibitors at FC Seminar 2007, being held October 15-17, 2007 at the convention center in San Antonio, TX. Dr. Carl Kukkonen, CEO of both VIASPACE and DMFCC, said, "We are demonstrating our new VIASENSOR HS-1000 Relative Humidity sensor, as well as one of our fuel cartridges working with a direct methanol fuel cell made by Parker Hannifin. Other recent cartridge and valve connector prototypes will be on display. The booth will be manned by the VIASPACE Energy and DMFCC staff from the US. We have also set up private meetings with potential customers and partners on new development efforts, including Tyco Electronics." VIASPACE Energy is focused on instrumentation for fuel cells and battery products. DMFCC focuses on producing and distributing methanol fuel cartridges designed to provide the energy source for laptop computers, cell phones and other portable electronic devices to be powered by direct methanol fuel cells. Fuel cells are expected to gain a substantial market share because they offer longer operating time as compared to current lithium ion batteries and may be instantaneously recharged by simply replacing the disposable fuel cartridge. Leading OEMs have announced that they are developing direct methanol fuel cells for portable electronic applications. Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com ! About OTCStockExchange.com OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com . We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at [email protected] . OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements. CONTACT: Chris Wheeler, OTCStockExchange.com Tel: +1 585 330 8514 e-mail: [email protected] WWW: http://www.otcstockexchange.com ((M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). Copyright 2007 M2 Communications Ltd. |